ANN HANHAM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANN HANHAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANN HANHAM. ANN HANHAM is a Director in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and a Director in SCYNEXIS INC ($SCYX) and a Director in ENDOCYTE INC ($ECYT) and a Director in IMMUNICON CORP ($IMMC).
Address: C/O BURRILL & COMPANY ONE EMBARCADERO CENTER, STE 2700 SAN FRANCISCO 94111 CA
Companies in which ANN HANHAM is an Insider
ENDOCYTE INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANN HANHAM: Director
Holdings: 7,800 shares
Current Value: $16,692
Latest Transaction: May 05 2017
$ECYT Market Capitalization: $88.76M
$ECYT Previous Close: $2.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HTG MOLECULAR DIAGNOSTICS, INC
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ANN HANHAM: Director
Holdings: 7,304 shares
Current Value: $13,439
Latest Transaction: Aug 21 2020
$HTGM Market Capitalization: $12.65M
$HTGM Previous Close: $1.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNICON CORP
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of ANN HANHAM: Director
Holdings: 350,000 shares
Latest Transaction: Apr 23 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SCYNEXIS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANN HANHAM: Director
Holdings: 3,622 shares
Current Value: $11,409
Latest Transaction: Dec 23 2020
$SCYX Market Capitalization: $82.53M
$SCYX Previous Close: $3.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ANN HANHAM
Sentiment: All, ECYT, HTGM, IMMC, SCYX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2020 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 8.25 | 1,600 | 13,200 | 1,600 | |
| Dec 23 2020 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Option Exercise | A | 7.33 | 1,600 | 11,728 | 1,600 | |
| Dec 23 2020 | SCYX | SCYNEXIS INC | HANHAM ANN | Director | Buy | P | 6.25 | 3,200 | 20,000 | 3,622 | 422 to 3.6 K (+758.29 %) |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Grant | A | 0.00 | 2,500 | 0 | 7,304 | 4.8 K to 7.3 K (+52.04 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | HANHAM ANN | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 |